150 related articles for article (PubMed ID: 29633731)
1. Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment.
Aldapt MB; Kassem N; Al-Okka R; Ghasoub R; Soliman D; Abdulla MA; Mudawi D; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):33-37. PubMed ID: 29633731
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment.
Losada R; Espinosa E; Hernández C; Dorticos E; Hernández P
Br J Haematol; 1996 Dec; 95(4):704-5. PubMed ID: 8982048
[TBL] [Abstract][Full Text] [Related]
3. A case of acute promyelocytic leukemia showing transient thrombocytosis caused by increased interleukin-6 and thrombopoietin after treatment with all-trans retinoic acid and chemotherapy.
Kondo M; Nakabayashi Y; Sugiyama A; Tominaga T; Shinohara K
Gan To Kagaku Ryoho; 2009 May; 36(5):827-30. PubMed ID: 19461187
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemia.
Kentos A; Le Moine F; Crenier L; Capel P; Meyer S; Muus P; Mandelli F; Feremans W
Br J Haematol; 1997 Jun; 97(3):685. PubMed ID: 9207423
[No Abstract] [Full Text] [Related]
5. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L; Pereira-Martins DA; Lima ASG; Baggio MS; de Araujo Koury LC; Lange AP; Bassi SC; Scheucher PS; Rego EM
BMC Cancer; 2020 Aug; 20(1):821. PubMed ID: 32859169
[TBL] [Abstract][Full Text] [Related]
6. Scrotal Ulcers Arising during Treatment with All-trans Retinoic Acid for Acute Promyelocytic Leukemia.
Shimizu D; Nomura K; Matsuyama R; Matsumoto Y; Ueda K; Masuda K; Taki T; Nishida K; Horiike S; Kishimoto S; Yanagisawa A; Taniwaki M
Intern Med; 2005 May; 44(5):480-3. PubMed ID: 15942099
[TBL] [Abstract][Full Text] [Related]
7. [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome].
Tsujioka T; Wada H; Yata K; Suemori S; Yamada O; Sugihara T
Rinsho Ketsueki; 2003 Jul; 44(7):474-6. PubMed ID: 12931568
[TBL] [Abstract][Full Text] [Related]
8. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of interleukin 6, interleukin 8 and their receptors in acute promyelocytic leukemia during all-trans retinoic acid induction treatment].
Zeng H; Zhang X; Chen Z
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):357-60. PubMed ID: 10921031
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day.
Lemez P
Eur J Haematol; 1995 Oct; 55(4):275-6. PubMed ID: 7589349
[No Abstract] [Full Text] [Related]
11. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
12. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
14. Perioperative retinoic acid syndrome in a patient with acute promyelocytic leukemia.
Usoltsev NA; Dhamee MS
J Clin Anesth; 2012 Jun; 24(4):315-7. PubMed ID: 22608587
[TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
16. [Experience in administration low dose all-trans retinoic acid for a child with acute promyelocytic leukemia].
Hata M; Nakayama T; Hattori T; Okano S; Ito T; Abe T; Kamakura M; Iinuma H; Okinaga K; Yasuda K
Rinsho Ketsueki; 1996 Feb; 37(2):129-33. PubMed ID: 8852030
[TBL] [Abstract][Full Text] [Related]
17. Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?
Dombret H; Geiger S; Daniel MT; Glaisner S; Micléa JM; Castaigne S; Merle-Beral H; Lacombe C; Chomienne C; Degos L
Leukemia; 1995 Sep; 9(9):1473-7. PubMed ID: 7658714
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia.
Cull GM; Eikelboom JW; Cannell PK
Hematol Oncol; 1997 Feb; 15(1):13-7. PubMed ID: 9378467
[TBL] [Abstract][Full Text] [Related]
19. Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA).
Hogan CJ; Wiley JS; Billington T
Aust N Z J Med; 1997 Aug; 27(4):450-1. PubMed ID: 9448894
[No Abstract] [Full Text] [Related]
20. The combined effects of all-trans retinoic acid and granulocyte colony-stimulating factor as a differentiation induction therapy for acute promyelocytic leukemia.
Tsurumi H; Tojo A; Takahashi T; Moriwaki H; Asano S; Muto Y
Intern Med; 1993 Aug; 32(8):648-50. PubMed ID: 7508772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
